Package 0169-2081-03

Brand: alhemo

Generic: concizumab
NDC Package

Package Facts

Identity

Package NDC 0169-2081-03
Digits Only 0169208103
Product NDC 0169-2081
Description

1 SYRINGE, PLASTIC in 1 CARTON (0169-2081-03) / 3 mL in 1 SYRINGE, PLASTIC

Marketing

Marketing Status
Marketed Since 2025-03-24
Brand alhemo
Generic concizumab
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "ff2589ac-650f-4740-984d-e950f785c1fc", "openfda": {"nui": ["N0000194160", "N0000194161"], "unii": ["68603V9EAF"], "rxcui": ["2708346", "2708353", "2708356", "2708359", "2708361", "2708362"], "spl_set_id": ["156f6404-1f6f-417f-bcf8-f07a27a82cc1"], "pharm_class_epc": ["Tissue Factor Pathway Inhibitor Antagonist [EPC]"], "pharm_class_moa": ["Tissue Factor Pathway Inhibitor Antagonists [MoA]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-2081-03)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0169-2081-03", "marketing_start_date": "20250324"}], "brand_name": "Alhemo", "product_id": "0169-2081_ff2589ac-650f-4740-984d-e950f785c1fc", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Tissue Factor Pathway Inhibitor Antagonist [EPC]", "Tissue Factor Pathway Inhibitor Antagonists [MoA]"], "product_ndc": "0169-2081", "generic_name": "concizumab", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Alhemo", "active_ingredients": [{"name": "CONCIZUMAB", "strength": "100 mg/mL"}], "application_number": "BLA761315", "marketing_category": "BLA", "marketing_start_date": "20250219", "listing_expiration_date": "20261231"}